Harvard Apparatus Regenerative Technology And Mayo Clinic Collaborate On Regenerated Trachea, Esophagus And Heart Valve

HOLLISTON, Mass.--(BUSINESS WIRE)--Harvard Apparatus Regenerative Technology, Inc., (NASDAQ: HART), or HART, has signed a joint development agreement with Mayo Clinic with the intent of developing and improving regenerative medicine treatments for severe diseases.


Help employers find you! Check out all the jobs and post your resume.